The 10th Annual Translational Microbiome Conference

The Annual Translational Microbiome Conference continues to be an integral venue for industry, academia and government to share microbiome research and connect with colleagues in the field. This meeting showcases ground-breaking research being performed by leadings scientists from around the globe. Attendees will have the opportunity to hear the leading companies and academicians discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes. Cutting-Edge Research: Immerse yourself in the latest breakthroughs, advancements, and scientific insights in microbiome research. Interdisciplinary Perspectives: Engage in stimulating discussions that bridge the gap between different disciplines, including microbiology, genomics, immunology and bioinformatics. Networking Opportunities: Connect with a diverse community of researchers, scientists, and industry professionals passionate about the microbiome. Poster Sessions and Oral Presentations: Showcase your own research findings or gain inspiration from the work of others through interactive poster sessions and oral presentations. Technology and Methodology Showcase: Explore cutting-edge technologies, innovative methodologies, and analytical tools that are revolutionizing microbiome research. Translational Applications: Discover how microbiome research is shaping our understanding of human health, disease, and therapeutics. Gain insights into the development of microbiome-based interventions.  Speakers: Christian Furlan Freguia, Ph.D. Sr. Vice President of Research Rise Therapeutics, Kevin Honaker, MBA Chief Executive Officer BiomeSense, Jaeyun Sung, Ph.D. Assistant Professor Mayo Clinic, Bruno Balen Co-Founder AniBiome, Leigh Frame, Ph.D. Executive Director of the Office of Integrative Medicine and Health, Associate Professor of Clinical Research and Leadership George Washington University School of Medicine and Health Sciences, Xochitl (Zochi) Morgan, Ph.D. Director, Harvard Chan Microbiome Analysis Center, Harvard Chan Microbiome in Public Health Center Harvard T.H. Chan School of Public Health, David Lyttle, Ph.D. Senior Bioinformatics Scientist Evvy, Kristopher Locken Research and Development Zymo Research, Tengteng Wang, Ph.D. Assistant Professor of Medicine, Division of Medical Oncology Rutgers Robert Wood Johnson Medical School, Jeffrey Salomon, MD, MBA Associate Professor, Division of Critical Care, Assistant Professor, Department of Physiology University of Nebraska College of Medicine, Julius Goepp, MD Chief Science Officer Evimero, James Moon, Ph.D. John Gideon Searle Professor, Department of Pharmaceutical Sciences University of Michigan Medical School, Matt Cheng, MD Co-Founder and Chief Executive Officer Kanvas Bio, Brantley Hall, Ph.D. Assistant Professor, Department of Cell Biology and Molecular Genetics University of Maryland, Paul Hergenrother, Ph.D. Kenneth L. Rinehart Endowed Chair in Natural Products Chemistry, Department of Chemistry University of Illinois, M. Ashfaqul Alam, Ph.D. Assistant Professor University of Kentucky College of Medicine, Tatiana Marquez-Lago, Ph.D. Associate Professor, Department of Genetics University of Alabama at Birmingham, Michael Abt, Ph.D. Associate Professor of Microbiology University of Pennsylvania, Scott Parkinson, Ph.D. Co-Founder Aqabela, Andrew Bartko, Ph.D. Professor of Practice, Executive Director for the Center for Microbiome Innovation, Professor of Practice, Pediatrics UC San Diego, Sameer Sonkusale, Ph.D. Founding Member, Chief Scientific Advisor/Professor, Biomedical Engineering Microvitality/Tufts University, Caroline Anderson Scientific Contributor/Microbiology Ph.D. Candidate Microvitality/MIT